Heart rate in patients with coronary artery disease - the lower the better? An analysis from the Treating to New Targets (TNT) trial

被引：0
|
作者：
Bangalore, S. [1 ]
Wun, C. C. [2 ]
Demicco, D. [2 ]
Breazna, A. [2 ]
Deedwania, P. [3 ]
Messerli, F. H. [4 ]
机构：
[1] NYU, Sch Med, New York, NY USA
[2] Pfizer, New York, NY USA
[3] Univ Calif San Francisco, Vet Affairs Med Ctr, Cardiol Sect, San Francisco, CA 94143 USA
[4] St Lukes Roosevelt Hosp, New York, NY 10025 USA
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [1] Lower is better: Implications of the Treating to New Targets (TNT) study for Canadian patients
    Fitchett, David H.
    Leiter, Lawrence A.
    Goodman, Shaun G.
    Langer, Anatoly
    CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 (10) : 835 - 839
  • [2] Usefulness of Heart Rate at Rest as a Predictor of Mortality, Hospitalization for Heart Failure, Myocardial Infarction, and Stroke in Patients With Stable Coronary Heart Disease (Data from the Treating to New Targets [TNT] Trial)
    Ho, Jennifer E.
    Bittner, Vera
    DeMicco, David A.
    Breazna, Andrei
    Deedwania, Prakash C.
    Waters, David D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (07): : 905 - 911
  • [3] Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The treating to new targets (TNT) study
    Shepherd, James
    Kastelein, John J. P.
    Bittner, Vera
    Deedwania, Prakash
    Breazna, Andrei
    Dobson, Stephen
    Wilson, Daniel J.
    Zuckerman, Andrea
    Wenger, Nanette K.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (06): : 1131 - 1139
  • [4] Lipid lowering in patients with treatment-resistant hypertension: an analysis from the Treating to New Targets (TNT) trial
    Bangalore, Sripal
    Fayyad, Rana
    Laskey, Rachel
    DeMicco, David
    Deedwania, Prakash
    Kostis, John B.
    Messerli, Franz H.
    EUROPEAN HEART JOURNAL, 2014, 35 (27) : 1801 - 1808
  • [5] Lessons from the BEAUTIfUL trial Heart rate targets for coronary patients
    不详
    CARDIOVASCULAR JOURNAL OF AFRICA, 2009, 20 (04) : 261 - +
  • [6] Emerging Cardiovascular Disease Biomarkers and Incident Diabetes Mellitus Risk in Statin-Treated Patients With Coronary Artery Disease (from the Treating to New Targets [TNT] Study)
    Arsenault, Benoit J.
    Kohli, Payal
    Lambert, Gilles
    DeMicco, David A.
    Laskey, Rachel
    Messig, Michael M.
    Kastelein, John J. P.
    Waters, David D.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (04): : 494 - 498
  • [7] J-Curve Revisited: An Analysis of the Treating to New Targets (TNT) Trial
    Bangalore, Sripal
    Messerli, Franz H.
    Wun, Chuan-Chuan
    Zuckerman, Andrea L.
    DeMicco, David
    Kostis, John B.
    LaRosa, John C.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A217 - A217
  • [8] Intensive Lipid Lowering with Atorvastatin in Patients with Treatment Resistant Hypertension: An Analysis from the Treating to New Targets (TNT) Trial
    Bangalore, Sripal
    Fayyad, Rana
    Laskey, Rachel
    Demicco, David
    Deedwania, Prakash
    Kostis, John B.
    Messerli, Franz
    CIRCULATION, 2012, 126 (21)
  • [9] The Benefits of Intensive Lipid Lowering in Patients With Stable Coronary Heart Disease With Normal or High Systolic Blood Pressure: An Analysis of the Treating to New Targets (TNT) Study
    Kostis, John B.
    Breazna, Andrei
    Deedwania, Prakash C.
    LaRosa, John C.
    JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (05): : 367 - 376
  • [10] Heart rate in coronary artery disease: Should we lower it?
    Axsom K.
    Bangalore S.
    Current Treatment Options in Cardiovascular Medicine, 2013, 15 (1) : 118 - 128
12345